Etienne Jornod

From Wikipedia, the free encyclopedia
Etienne Jean Jornod
Born (1953-01-06) January 6, 1953 (age 71)
Neuchâtel, Switzerland
Education
Occupation(s)former Chairman of the Board of Directors of the pharmaceutical and logistics group Galenica and the NZZ Mediengruppe
Children4

Etienne Jean Jornod (born 6 January 1953 in Neuchâtel, Switzerland)[1] is a Swiss entrepreneur and manager. He was Chairman of the Board of Directors of the pharmaceutical and logistics group Galenica and the NZZ Mediengruppe.

Life and education[edit]

Etienne Jornod grew up in Neuchâtel as the eldest of six children in a family of doctors[2] and completed an apprenticeship as a pharmacist in Biel. He studied business administration[3] at the HEC Lausanne and graduated with a licentiate (lic. Oec). He continued his studies at the Stanford University in the United States (Senior Executive Program).

Career[edit]

In 1975, he joined Galenica as a Junior Product Manager, leaving the company in 1978 to study business administration. He returned to the company in 1981 as Assistant to the Directorate General. He has been a member of the Directorate General since 1989, and from 1996 to 2011, he led Galencia‘s dual mandate as President and Delegate of the Board of Directors. Since 2012, he has been executive chairman of the board.[4][1]

From April 2013 to April 2023, he was Chairman of the Board of the NZZ-Mediengruppe. He succeeded Franz Steinegger, who had retired from the board after reaching the age for retirement.[5]

Etienne Jornod held other directorships, including President of Vifor Pharma AG and Vifor Fresenius Medical Care Renal Pharma AG.[6] From 2012 to 2017 he was a member of the Board of Directors of Vaudoise Insurance Group.[7] From 2008 to 2009 he was a member of the board of Publigroupe. He was also a directorial member of Alliance Boots.[4]

In May 2020, Jornod stepped down as executive chairman of Vifor Pharma's board of directors after 25 years of service,[8] and was named honorary chairman of the company that same month, after having previously been appointed Honorary Chairman of Galenica in 2017.[9]

In 2020, together with long-term partners, he acquired the Geneva-based biotech company OM Pharma from Vifor Pharma and has since been the company's executive chairman of the Board of Directors. He is also President of the Advisory Board of the University of Lucerne.[10]

Personal life[edit]

Etienne Jornod is in his second marriage, the father of four children, two of them from his first marriage.[2] He lives in Muri bei Bern.[1]

References[edit]

  1. ^ a b c Ueli Kneubühler (11 December 2012). "Machtnetz von Etienne Jornod: Der Unerfahrene". Bilanz Ringier Axel Springer Schweiz. Retrieved 17 January 2018.
  2. ^ a b Hanspeter Bürgin (December 2012). "Ich bin diskret" (PDF). Bantel & Partner. Retrieved 17 January 2018.
  3. ^ Dominik Feldges, Mark Dittli (14 January 2014). "Galenica ist nicht Jornod-abhängig". Finanz und Wirtschaft. Retrieved 17 January 2018.
  4. ^ a b "Les Barons de la Bourse". Zonebourse. Retrieved 17 January 2018.
  5. ^ "NZZ-Verwaltungsrat schlägt Etienne Jornod als neuen Präsidenten vor". Neue Zürcher Zeitung NZZ. 26 October 2012. Retrieved 17 January 2018.
  6. ^ "Etienne Jean Jornod". Moneyhouse NZZ. Retrieved 17 January 2018.
  7. ^ "Etienne Jornod zieht sich aus Vaudoise-Verwaltungsrat zurück". kleinreport.ch. 6 April 2017. Retrieved 30 October 2023.
  8. ^ "Vifor Pharma Group Reports Strong Growth in 2019, Exceeding Raised Guidance". Business Wire. 12 March 2020. Retrieved 15 September 2021.
  9. ^ "92nd Vifor Pharma Group Annual General Meeting". Business Wire. 14 May 2020. Retrieved 13 September 2021.
  10. ^ "Etienne Jornod". unternehmen.nzz.ch. Archived from the original on 31 January 2023. Retrieved 30 October 2023.

External links[edit]

Retrieved from "https://en.wikipedia.org/w/index.php?title=Etienne_Jornod&oldid=1214196320"